This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Disorders of purine and pyrimidine metabolism
E4_PURINEPYRI
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
195 |
6. Filter based on genotype QC (FinnGen only) |
195 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E70-E90
- Name in latin
- Perturbationes metabolismi purini et pyrimidini
Similar endpoints
↥List of similar endpoints to
Disorders of purine and pyrimidine metabolism
based on the number of shared cases.
Similar with more cases:
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 195 | 76 | 119 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 64.95 | 61.89 | 66.90 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 177
- Matched controls
- 1770
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E79.0
ICD-10 Finland
Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
+∞
194.5
149
*
M04AA01
ATC
allopurinol; systemic
15.1
51.6
100
140
M10.9
ICD-10 Finland
Gout, unspecified
9.9
21.3
45
59
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
211.5
18.9
19
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.1
16.4
48
101
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
8.4
15.9
36
52
C03CA01
ATC
furosemide; systemic
4.0
15.9
85
332
H02AB06
ATC
prednisolone; systemic
3.8
15.8
113
564
E79.9
ICD-10 Finland
Disorder of purine and pyrimidine metabolism, unspecified
+∞
14.8
14
*
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
6.3
14.0
39
76
212
Kela drug reimbursment
Gout
15.5
13.7
22
16
205
Kela drug reimbursment
Chronic hypertension
3.5
13.2
80
335
P01BA02
ATC
hydroxychloroquine; oral
6.3
13.0
36
69
I10
ICD-10 Finland
Essential (primary) hypertension
3.4
13.0
128
764
A10BH05
ATC
linagliptin; oral
10.6
13.0
25
27
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
75.4
12.8
14
*
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
12.4
12.4
22
20
L28
ICPC
Limited function/disability (L)
4.3
12.3
50
148
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
6.9
12.2
31
53
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
12.1
102
531
M10.0
ICD-10 Finland
Idiopathic gout
10.4
11.9
23
25
E79.8
ICD-10 Finland
Other disorders of purine and pyrimidine metabolism
+∞
11.6
11
*
C08CA01
ATC
amlodipine; oral
3.1
11.6
88
423
N17.9
ICD-10 Finland
Acute renal failure, unspecified
11.2
11.4
21
21
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
6.7
11.3
29
50
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.0
11.0
48
150
M13.9
ICD-10 Finland
Arthritis, unspecified
5.9
11.0
31
61
I50.9
ICD-10 Finland
Heart failure, unspecified
4.2
10.9
45
134
A46
ICD-10 Finland
Erysipelas
4.1
10.7
45
136
C10AA05
ATC
atorvastatin; oral
3.0
10.6
89
450
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
12.4
10.3
18
16
J01FF01
ATC
clindamycin; systemic
3.1
9.9
70
312
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
5.2
9.9
31
69
C07AB07
ATC
bisoprolol; oral
2.8
9.7
106
621
AN1
HP
Coronary angiography
4.7
9.4
33
83
H02AB07
ATC
prednisone; oral
4.0
9.3
39
117
C10AA01
ATC
simvastatin; oral
2.7
9.2
99
567
J01DB01
ATC
cefalexin; oral
3.4
9.1
153
1150
A10BA02
ATC
metformin; oral
2.9
8.9
68
317
A07EC01
ATC
sulfasalazine; oral, rectal
4.6
8.8
31
78
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
17.4
8.7
13
8
A02BC02
ATC
pantoprazole; systemic
2.7
8.7
127
856
288
Kela drug reimbursment
Febuxostat
29.1
8.6
11
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.4
8.6
46
167
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
3.1
8.4
53
217
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
5.8
8.4
23
44
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.9
8.3
27
63
103
Kela drug reimbursment
Diabetes, insulin-treated
2.8
8.2
66
311
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.9
8.1
59
262
C03DA01
ATC
spironolactone; oral
4.1
8.1
32
91
N02BE01
ATC
paracetamol; systemic, rectal
3.6
8.0
159
1259
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
8.0
67
324
E66.00
ICD-10 Finland
Metabolic syndrome
7.0
8.0
19
30
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
7.9
39
133
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.9
7.9
33
98
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.3
7.9
43
158
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
10.7
7.7
14
14
M04AA03
ATC
febuxostat; oral
26.3
7.7
10
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.1
7.5
29
80
E66.9
ICD-10 Finland
Obesity, unspecified
11.6
7.4
13
12
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
4.8
7.4
24
56
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
5.2
7.3
22
47
G47.3
ICD-10 Finland
Sleep apnoea
2.8
7.3
52
226
R50.9
ICD-10 Finland
Fever, unspecified
3.3
7.2
37
130
349
Kela drug reimbursment
Febuxostat
21.1
7.2
10
5
R06.0
ICD-10 Finland
Dyspnoea
2.7
7.0
56
263
WX722
NOMESCO Finland
PEEP
5.4
6.9
20
41
J01MA12
ATC
levofloxacin; systemic
2.9
6.9
45
185
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
8.3
6.8
14
18
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
6.7
54
252
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.5
6.7
23
57
S97
ICPC
Chronic ulcer skin
5.8
6.7
18
34
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
7.9
6.6
14
19
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
6.5
68
363
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
6.5
23
59
N19
ICD-10 Finland
Unspecified kidney failure
6.4
6.5
16
27
E87.5
ICD-10 Finland
Hyperkalaemia
72.3
6.5
7
*
C10AA07
ATC
rosuvastatin; oral
2.6
6.4
51
237
N02AX02
ATC
tramadol; systemic, rectal
2.3
6.4
87
527
SPAT1229
SPAT
Assessment of need for aid
4.3
6.4
23
60
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
6.7
6.3
15
24
E86
ICD-10 Finland
Volume depletion
27.8
6.3
8
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
4.0
6.2
24
67
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.7
6.2
44
190
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
4.8
6.1
19
43
T90
ICPC
Diabetes non-insulin dependent
2.5
6.0
52
249
E000001
ATC
NA
2.7
6.0
44
195
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003458) Phosphate [Moles/volume] in Serum or Plasma
80
152
8.23
44.57
10.4
5.7
mmol/l
1.1
1.0
1.53
75
136
(3026493) Urate [Moles/volume] in Serum or Plasma
128
414
7.09
40.93
5.9
2.5
umol/l
429.9
7619.7
1.98
115
350
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
43
99
5.29
18.41
7.9
3.1
ng/l
108.7
81.4
1.06
38
87
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
67
221
4.10
18.18
4.9
2.1
%
20.1
23.9
1.35
59
191
(3023368) Bacteria identified in Blood by Culture
101
443
3.66
17.91
6.7
4.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
139
749
3.98
17.90
15.0
6.2
mmol/l
1.2
1.2
0.92
113
636
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
131
687
3.76
17.40
13.8
5.6
mmol/l
1.2
1.2
0.78
120
616
(1616796) Gas panel - Central venous blood
21
24
9.69
17.10
7.0
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
41
100
4.93
16.31
2.4
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
47
130
4.45
15.98
3.5
3.1
e9/l
75.4
70.5
0.46
36
102
(3002032) Base excess in Venous blood by calculation
48
137
4.32
15.65
9.1
3.5
mmol/l
1.6
2.1
0.24
33
104
(3012095) Magnesium [Moles/volume] in Serum or Plasma
64
226
3.73
15.46
4.4
3.8
mmol/l
0.8
0.8
1.52
57
207
(3024561) Albumin [Mass/volume] in Serum or Plasma
125
677
3.36
14.94
8.2
4.3
g/l
33.0
35.5
4.41
120
625
(3012544) pH of Venous blood
48
143
4.13
14.72
9.0
3.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
112
581
3.18
14.17
2.9
2.0
nmol/l
72.9
76.8
0.68
102
513
(3027945) Reticulocytes/100 erythrocytes in Blood
54
180
3.77
14.09
3.0
2.7
%
2.1
1.8
1.51
48
165
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
29
59
5.60
14.08
8.5
4.6
mmol/l
24.6
23.5
0.85
22
51
(3001604) Monocytes [#/volume] in Blood
132
759
3.29
13.86
8.4
5.9
e9/l
0.7
0.6
1.58
120
664
(3006315) Basophils [#/volume] in Blood
132
764
3.25
13.60
8.8
5.9
e9/l
0.0
0.0
0.01
121
674
(3013115) Eosinophils [#/volume] in Blood
134
787
3.25
13.37
8.8
6.0
e9/l
0.2
0.2
0.08
118
708
(3026782) Osmolality of Urine
73
305
3.23
13.25
4.4
2.5
mosm/kgh2o
518.7
563.5
1.10
63
251
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
32
75
4.91
13.23
2.1
1.7
g/l
1.7
1.5
0.56
27
63
(3042936) Bacteria identified in Isolate by Culture
63
242
3.37
13.12
3.1
2.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
23
41
6.23
12.75
1.6
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
65
259
3.26
12.70
2.2
1.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
131
777
3.09
12.51
9.0
6.0
e9/l
1.9
1.9
0.17
121
701
(3014111) Lactate [Moles/volume] in Serum or Plasma
45
143
3.79
12.48
12.6
4.7
mmol/l
1.9
1.4
0.75
39
137
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
92
451
2.97
12.47
2.5
2.0
u/l
143.8
180.5
0.70
86
420
(3004588) Protein electrophoresis panel - Serum or Plasma
38
109
4.09
12.14
2.0
1.5
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
140
874
3.13
11.96
12.9
9.9
e9/l
4.6
4.1
1.96
129
787
(3032080) INR in Blood by Coagulation assay
116
661
2.86
11.62
12.4
9.6
inr
1.3
1.3
0.02
28
187
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
191
3.35
11.50
1.9
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
156
1056
3.39
11.18
6.6
4.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
39
121
3.78
11.13
19.4
6.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
95
500
2.75
10.92
9.8
5.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
87
438
2.78
10.90
3.7
2.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
111
633
2.75
10.87
2.6
2.0
pmol/l
76.2
95.6
5.34
69
345
(3013826) Glucose [Moles/volume] in Serum or Plasma
144
943
3.02
10.72
9.1
4.6
mmol/l
7.4
6.8
1.88
136
878
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
51
194
3.21
10.58
1.8
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
12
12
10.59
10.54
2.4
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
88
456
2.69
10.29
9.9
3.7
ph
7.4
7.4
0.14
23
93
(3003396) Base excess in Arterial blood by calculation
49
185
3.20
10.27
11.4
8.0
mmol/l
1.2
1.4
0.07
35
142
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
30
84
4.04
9.83
1.8
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
103
589
2.59
9.70
5.8
3.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
26
6.61
9.62
5.6
2.2
%
17.1
16.6
—
10
11
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
20
41
5.32
9.54
1.3
1.3
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
48
188
3.06
9.39
11.6
7.8
kpa
5.1
5.2
0.09
43
175
(3027801) Oxygen [Partial pressure] in Arterial blood
48
188
3.06
9.39
11.6
7.9
kpa
10.7
11.9
0.75
43
176
(3020682) Albumin/Creatinine [Ratio] in Urine
88
475
2.55
9.25
6.1
3.7
mg/mmol
29.1
5.0
2.76
67
290
(3019309) Folate [Moles/volume] in Red Blood Cells
66
310
2.71
9.21
2.1
1.7
nmol/l
1311.2
1191.8
0.45
53
238
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
91
501
2.53
9.15
3.1
2.4
u/l
66.0
57.2
0.48
86
456
(3018010) Neutrophils/100 leukocytes in Blood
116
720
2.51
8.93
8.9
5.9
%
59.7
57.4
1.18
111
679
(3009508) Creatinine [Moles/volume] in Urine
86
466
2.51
8.89
4.9
3.0
mmol/l
6.4
7.9
3.62
76
378
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
129
844
2.56
8.82
8.6
6.7
umol/l
11.7
11.7
0.00
124
790
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
74
375
2.57
8.79
3.1
2.0
mg/l
4.1
3.3
1.35
65
330
(3012516) Albumin [Mass/volume] in Urine
83
445
2.51
8.75
4.9
3.1
mg/l
146.4
35.9
3.07
62
286
(40760892) CBC W Ordered Manual Differential panel - Blood
67
326
2.61
8.64
6.0
5.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
119
760
2.45
8.42
5.9
3.5
estimate
0.0
0.0
0.00
32
143
(3021440) Promyelocytes/100 leukocytes in Blood
37
132
3.23
8.42
3.4
5.0
%
0.5
0.2
0.69
13
40
(3014007) Fractional oxyhemoglobin in Arterial blood
31
99
3.53
8.39
15.2
6.1
%
89.8
93.9
0.67
31
99
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
39
144
3.14
8.38
2.9
2.3
ug/l
3.2
7.3
1.56
30
130
(3021601) Nitrite [Presence] in Urine by Test strip
118
756
2.42
8.22
7.7
4.6
estimate
0.0
0.0
0.00
34
143
(3020891) Body temperature
26
75
3.85
8.14
8.6
3.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
55
249
2.68
8.14
1.3
1.3
u/ml
30.1
13.8
0.62
19
95
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
89
506
2.40
8.11
6.1
3.2
ng/l
3262.2
1220.4
1.84
79
433
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
52
4.41
8.03
1.9
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
46
191
2.84
8.02
1.3
1.4
titre
323.6
523.9
0.61
11
41
(3017181) Myelocytes/100 leukocytes in Blood
38
142
3.08
7.99
3.7
4.8
%
0.6
1.2
1.01
13
46
(3009261) Glucose [Presence] in Urine by Test strip
119
772
2.39
7.96
5.9
3.6
estimate
0.0
0.0
0.00
30
143
(3013707) Erythrocyte sedimentation rate by Westergren method
155
1139
2.76
7.82
7.1
4.1
mm/h
22.1
12.8
7.14
148
1043
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
17
36
5.08
7.80
1.7
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
15
29
5.52
7.58
2.0
1.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
99
603
2.30
7.55
5.4
2.4
ug/l
225.6
149.6
1.36
88
555
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
22
6.26
7.48
1.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
29
97
3.34
7.28
5.5
3.2
mmol/l
2.4
1.8
0.20
19
77
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
53
250
2.54
7.13
1.5
1.3
iu/ml
45.7
36.1
0.19
19
84
(3002179) Metamyelocytes/100 leukocytes in Blood
33
122
3.05
7.03
2.8
4.9
%
0.4
0.5
—
7
29
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
12
20
6.33
6.99
4.7
1.8
—
—
—
0
0
(3009343) pH of Capillary blood
30
106
3.16
6.89
5.6
3.1
ph
7.4
7.4
—
6
10
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
26
84
3.42
6.88
7.7
3.2
%
58.6
43.4
2.59
26
84
(3031040) Bacteria [#/volume] in Urine by Automated count
140
1009
2.37
6.88
5.7
4.4
—
3473.5
—
0
17
(21494890) Protein electrophoresis panel - 24 hour Urine
10
14
7.47
6.76
1.2
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
77
439
2.25
6.70
5.3
3.0
e6/l
0.5
0.4
0.23
68
327
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
41
4.45
6.70
2.0
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
32
120
2.99
6.64
3.4
5.3
%
0.0
0.0
—
8
31
(3019060) Gas panel - Arterial blood
32
120
2.99
6.64
5.0
7.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
52
251
2.46
6.62
2.0
1.4
g/l
3.0
2.8
0.18
39
153
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
101
646
2.17
6.56
6.6
3.5
ng/l
42.7
86.3
0.40
77
473
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
42
4.34
6.50
2.0
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
34
134
2.86
6.46
2.1
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
32
122
2.94
6.45
2.0
2.0
nmol/l
327.9
384.3
0.66
27
110
(3018095) Leukocytes [#/volume] in Urine
90
553
2.17
6.44
6.0
3.4
e6/l
310.7
102.6
0.44
74
412
(3015377) Calcium [Moles/volume] in Serum or Plasma
85
512
2.17
6.39
3.2
3.2
mmol/l
2.3
2.4
0.35
75
444
(3002582) Erythrocytes [#/volume] in Urine
82
487
2.18
6.39
5.2
3.1
e6/l
82.4
186.8
0.34
70
382
(3000850) Epithelial cells [#/volume] in Urine
63
336
2.29
6.38
3.9
2.6
e6/l
5.2
4.2
0.28
54
295
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
26
5.29
6.32
1.9
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
76
442
2.18
6.21
5.9
3.9
estimate
0.0
0.0
0.00
29
136
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
19
53
3.86
6.21
1.5
1.4
g/l
0.1
0.0
0.48
19
48
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
15
35
4.56
6.14
4.5
1.9
u/ml
0.2
0.4
—
10
20
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
31
4.79
6.09
2.0
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
70
399
2.18
5.98
2.0
1.6
nmol/l
18.9
21.0
0.56
63
337
(3025941) Bacteria identified in Stool by Culture
21
65
3.50
5.92
1.4
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
28
4.90
5.83
1.7
1.4
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
18
51
3.79
5.75
1.6
1.3
g/l
0.0
0.0
0.00
18
46
(3028271) Lactate [Moles/volume] in Capillary blood
11
21
5.49
5.59
2.7
1.4
mmol/l
1.9
1.5
0.90
11
21
(3037121) Protein [Mass/volume] in Urine
17
48
3.78
5.46
2.6
3.0
g/l
0.2
0.2
—
9
16
(36304419) Bacteria [Presence] in Urine
72
428
2.08
5.43
5.3
3.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
33
140
2.63
5.43
2.3
2.2
ug/g
330.8
114.6
0.81
28
122
(3022806) Fractional oxyhemoglobin in Capillary blood
10
18
5.80
5.38
3.0
1.2
%
89.7
88.8
—
10
18
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
48
244
2.28
5.35
4.3
2.8
e6/l
3.5
1.8
0.70
33
133
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
35
4.23
5.26
2.1
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
40
189
2.40
5.26
2.4
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
143
2.57
5.20
5.5
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
93
614
1.98
5.19
6.2
3.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
34
150
2.53
5.16
2.2
1.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
66
3.26
5.11
1.5
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
23
5.01
5.08
1.5
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
61
3.34
5.07
1.6
1.3
g/l
9.9
10.7
0.52
19
54
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
18
57
3.38
4.90
1.6
1.2
g/l
36.3
37.0
0.19
18
49
(3044640) Blood type and Crossmatch panel - Blood
75
467
1.98
4.89
3.4
2.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
101
696
1.94
4.88
5.3
4.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
50
268
2.16
4.87
4.1
2.7
e6/l
0.8
0.9
0.24
36
156
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
33
4.15
4.79
1.5
2.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
29
4.34
4.70
5.4
2.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
25
4.60
4.62
4.6
3.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
24
94
2.77
4.59
1.6
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
64
387
1.97
4.47
10.9
6.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
37
184
2.25
4.30
2.2
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
14
41
3.60
4.27
5.2
2.0
kpa
8.4
8.0
0.25
14
34
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
166
2.27
4.12
5.0
3.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
57
342
1.94
4.02
6.1
3.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
95
672
1.81
3.98
16.9
9.5
e9/l
0.0
0.0
0.50
83
554
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
35
179
2.16
3.79
2.4
2.9
umol/l
9.7
8.5
0.16
29
158
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
58
357
1.89
3.77
3.3
2.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
176
1536
2.50
3.70
34.3
14.3
mg/l
26.5
24.7
0.35
165
1218
(3013512) EKG study
76
517
1.77
3.54
5.4
3.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
47
275
1.93
3.53
1.4
1.2
u/ml
0.7
1.7
0.71
15
69
(40760888) Immunoglobulin light chains.free panel - Serum
11
31
3.70
3.53
3.6
3.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
35
185
2.09
3.48
1.2
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
65
425
1.79
3.45
5.0
3.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
15
53
2.98
3.44
5.2
1.9
ug/l
209.5
182.1
0.25
15
48
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
18
5.19
3.41
1.3
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
57
360
1.82
3.38
7.0
3.5
%
89.9
90.2
0.04
57
353
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
26
124
2.27
3.32
5.2
2.8
ml/min/173m2
32.9
64.5
6.92
17
50
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
27
132
2.21
3.26
7.6
3.4
mmol/l
1.2
1.2
0.33
27
118
(40768797) Stomach Pathology biopsy report
39
220
1.97
3.25
1.3
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
28
3.71
3.24
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
28
3.71
3.24
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
15
55
2.87
3.23
2.2
1.8
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
15
5.51
3.22
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
44
3.09
3.20
1.1
1.0
—
—
—
0
0
(44790047)
9
20
4.66
3.15
2.4
1.5
—
—
—
0
0
(44806118)
9
20
4.66
3.15
2.4
1.5
—
—
—
0
0
(44790049)
9
20
4.66
3.15
2.4
1.5
—
—
—
0
0
(44790048)
9
20
4.66
3.15
2.4
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
121
957
1.70
3.14
4.0
3.0
u/l
69.8
48.6
1.01
115
885
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
12
6.00
3.05
1.3
1.2
—
—
—
0
0
(4062490)
7
12
6.00
3.05
1.4
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
12
6.00
3.05
1.0
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
21
4.44
3.03
1.8
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
17
4.86
2.95
2.6
2.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
17
4.86
2.95
2.6
2.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
17
4.86
2.95
2.6
2.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
17
4.86
2.95
1.4
1.4
—
—
—
0
0
(4306422)
7
13
5.54
2.89
1.4
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
9
6.83
2.89
1.3
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
11
36
3.18
2.85
3.6
2.6
nmol/l
0.8
0.7
—
5
27
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
158
1366
1.83
2.77
5.7
4.4
mu/l
2.0
1.9
0.38
149
1215
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
25
127
2.11
2.75
3.6
3.4
ng/l
459.4
206.7
1.02
25
114
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
10
6.15
2.72
1.3
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
8
19
4.34
2.71
1.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
20
4.12
2.59
1.9
2.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
20
4.12
2.59
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
20
4.12
2.59
1.1
1.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
33
3.14
2.56
1.8
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
18
82
2.32
2.56
4.7
3.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
11
5.59
2.56
1.0
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
11
5.59
2.56
1.3
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
287
1.74
2.53
4.4
3.6
ng/l
1003.4
292.4
0.35
39
221
(40768443) Skin Pathology biopsy report
17
76
2.35
2.52
1.1
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
16
4.50
2.50
1.4
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
16
4.50
2.50
2.1
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
10
34
3.05
2.45
1.5
1.5
ug/g
364.8
257.0
—
5
19
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
12
5.12
2.42
2.0
3.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
12
5.12
2.42
2.3
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
6
12
5.12
2.42
1.3
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48
316
1.69
2.40
3.4
1.7
mg/l
1.5
1.4
0.12
36
246
(3019230) Fractional oxyhemoglobin in Venous blood
8
22
3.75
2.39
4.9
1.6
%
66.5
64.4
—
8
22
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
5
8
6.38
2.38
1.4
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
8
6.38
2.38
1.4
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
8
6.38
2.38
1.0
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
13
4.72
2.29
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
13
4.72
2.29
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
13
4.72
2.29
1.2
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
42
2.72
2.22
1.4
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
14
4.38
2.16
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
14
4.38
2.16
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
14
4.38
2.16
1.2
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
6
14
4.38
2.16
1.2
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
47
320
1.62
2.06
2.0
1.8
pmol/l
508.5
438.0
0.69
41
266
(40761536) Microorganisms panel - Urine sediment
23
127
1.92
2.04
5.2
3.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
32
2.90
2.03
2.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
32
2.90
2.03
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
92
2.05
1.97
2.4
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
78
2.15
1.97
23.3
14.7
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
130
1110
1.51
1.97
4.9
3.6
pmol/l
15.0
14.9
0.15
115
989
(3052851) Hemolysis interference index of Serum or Plasma
11
45
2.53
1.96
5.3
3.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
9
33
2.81
1.96
1.2
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
16
3.83
1.95
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
16
3.83
1.95
4.5
3.4
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
86
2.07
1.91
2.4
2.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
34
2.72
1.89
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
25
146
1.82
1.89
5.7
3.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
28
2.93
1.88
3.6
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
28
2.93
1.88
3.8
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
175
1610
1.85
1.85
33.1
13.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
6
17
3.61
1.85
1.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
17
3.61
1.85
1.0
1.0
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
23
3.12
1.81
3.1
2.5
e9/l
3.2
4.3
—
7
23
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
23
3.12
1.81
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
30
2.74
1.74
1.0
1.8
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
32
207
1.65
1.71
22.2
7.3
—
—
—
0
0
(3044889) 12 lead EKG panel
129
1116
1.46
1.70
5.7
4.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
42
2.46
1.70
1.6
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
19
3.22
1.67
1.3
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
56
415
1.49
1.67
2.0
1.7
mmol/l
1.7
1.3
2.54
51
343
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
49
2.32
1.67
1.4
2.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
25
2.86
1.66
3.6
3.4
%
54.0
55.4
—
7
25
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
14
3.64
1.62
1.0
1.0
—
1.1
—
0
5
(36660697) Celiac disease serology panel - Serum
17
92
1.93
1.62
1.1
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
32
2.56
1.61
1.8
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
12
57
2.18
1.58
2.4
3.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
131
1.77
1.57
1.4
1.4
—
—
—
0
0
(4268621)
5
15
3.39
1.53
2.8
2.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
21
2.91
1.51
4.3
2.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
29
189
1.63
1.51
1.8
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
149
1343
1.46
1.45
31.7
15.1
%
37.8
39.8
1.11
86
909
(21494434) Karyotype in Bone marrow
5
16
3.18
1.44
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
9
40
2.31
1.42
1.7
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
9
41
2.25
1.39
1.7
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
9
41
2.25
1.39
1.7
1.2
—
—
—
0
0
(4035726)
21
129
1.70
1.36
1.3
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
158
1448
1.48
1.33
9.3
5.8
mmol/mol
43.2
39.9
2.96
148
1333
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
62
2.00
1.31
1.7
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
48
2.14
1.30
2.9
1.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
18
2.82
1.29
8.2
2.3
nmol/l
5.8
3.8
—
5
18
(3038515) Glucose [Moles/volume] in Venous blood
8
35
2.34
1.28
4.0
2.9
mmol/l
6.9
7.7
—
8
35
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
45
2.05
1.25
1.1
1.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
19
2.67
1.22
1.4
1.3
nmol/l
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94
800
1.34
1.20
3.2
2.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
27
184
1.54
1.19
4.5
4.7
ug/l
3.0
62.5
0.81
19
158
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
20
2.54
1.16
2.8
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
20
2.54
1.16
1.2
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
40
2.04
1.13
4.0
2.7
mmol/l
1.4
1.7
—
8
40
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
51
2.01
1.13
3.6
2.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
22
145
1.58
1.12
1.7
2.0
%
1.7
1.5
0.39
17
126
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
7
31
2.30
1.11
1.0
1.4
e6/l
249.0
256.8
—
7
26
(3051611) Lipemic interference index of Serum or Plasma
5
21
2.42
1.09
5.4
2.5
—
—
—
0
0
(4010399)
19
122
1.62
1.07
1.5
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
18
114
1.64
1.07
2.1
3.0
e9/l
4.4
3.8
0.32
13
90
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
23
2.20
0.98
2.0
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
86
1.68
0.93
1.9
3.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
42
1.94
0.90
10.1
3.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
72
614
1.27
0.85
1.7
2.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
31
1.96
0.85
1.2
1.2
—
—
—
0
0
(4034850)
8
46
1.77
0.83
14.1
12.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
81
1.65
0.83
1.2
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
74
1.66
0.80
8.2
3.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
33
1.84
0.79
1.2
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
24
2.11
0.75
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
24
2.11
0.75
2.0
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
164
1558
1.33
0.72
6.6
5.0
mmol/l
2.5
2.7
3.02
152
1413
(3044290) Cell count panel - Cerebral spinal fluid
5
26
1.95
0.71
1.0
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
5
91
0.54
0.69
1.2
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
27
208
1.35
0.66
4.9
4.6
%
28.4
31.9
1.11
20
142
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
5
29
1.74
0.64
1.2
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
29
1.74
0.64
1.4
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
155
1470
1.27
0.63
5.4
4.0
mmol/l
1.8
1.3
8.03
140
1329
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
160
1529
1.26
0.56
6.0
4.4
mmol/l
4.3
4.6
2.14
148
1401
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
159
1519
1.25
0.56
5.9
4.4
mmol/l
1.3
1.4
4.35
146
1381
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
82
740
1.19
0.53
4.4
5.3
ug/l
2.5
2.8
0.16
71
665
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
158
1517
1.22
0.47
5.9
4.8
mmol/l
6.4
6.0
2.59
142
1378
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
10
69
1.47
0.45
3.5
11.1
%
1.6
1.6
—
10
62
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
10
70
1.45
0.42
2.2
3.6
u/ml
23.4
1674.6
—
10
58
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
33
1.53
0.41
1.4
1.2
—
1.1
—
0
5
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
33
1.53
0.41
1.4
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
15
0.00
0.41
0.0
3.7
—
54.7
—
0
15
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
0
15
0.00
0.41
0.0
1.1
—
7.6
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
1.5
—
0
5
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
10.3
—
0
7
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
1.7
—
0
7
(3003694) ABO and Rh group [Type] in Blood
45
395
1.18
0.40
1.5
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
9
117
0.76
0.28
3.0
3.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
63
1.28
0.28
3.4
1.6
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
12
96
1.27
0.25
1.2
1.3
—
27.5
—
0
11
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
39
1.29
0.23
1.4
1.3
—
1.8
—
0
9
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
39
1.29
0.23
1.4
1.3
—
1.9
—
0
7
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
47
506
0.91
0.20
3.4
2.8
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
8
69
1.17
0.16
2.3
11.1
%
0.7
0.9
—
8
61
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
13
111
1.18
0.16
2.2
2.4
—
5.4
—
0
6
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
22
199
1.12
0.14
1.6
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
5
44
1.14
0.10
1.0
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
148
1460
1.06
0.09
31.2
13.5
ml/min/173m2
64.1
77.2
7.03
135
1232
(3000492) Spirometry study
14
127
1.11
0.08
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
42
432
0.96
0.04
3.3
3.1
ug/l
0.8
0.7
0.07
37
307
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
15
143
1.05
0.01
1.5
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
59
598
0.98
0.01
4.3
4.7
%
21.8
21.3
0.09
33
320
(3002256) Pathology report gross observation
21
205
1.03
0.00
1.3
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.7
—
766.6
—
0
7
(3035933) Granulocytes/100 leukocytes in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
126
1260
1.00
0.00
46.5
19.2
g/l
329.5
332.3
2.54
126
1252
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
5.4
—
0
7
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
27.9
—
0
9
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
8.7
—
0.7
—
0
7
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
8.1
—
1003.1
—
0
7
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
8
0.00
0.00
0.0
1.0
—
8.9
—
0
8
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
63
0.95
0.00
1.3
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
18.3
—
0
5
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
29.6
—
0
5
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
13.9
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
7.6
—
0
7
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
7.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
204.4
—
0
7
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4211845)
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: E4_PURINEPYRI – Disorders of purine and pyrimidine metabolism
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).